Aside from their expression patterns their sequence polymorphisms can also provide valuable insights such as those of MEG3 in breast cancer which have been associated with therapeutic efficacy, therefore making them valuable predictive markers for patients [129]. This evidence concerns the gene MEG3 and breast carcinoma.